India Thyroid Function Test Market Is Witnessing Robust Growth With Horizon Therapeutics Ireland Dac Receiving The U.S. Food And Drug Administration (FDA) Approval For Tepezza, The First Treatment Of Thyroid Eye Disease
Most thyroid function tests are based on the detection of thyroid hormones in plasma or serum. The most widely used thyroid hormone is T4 (thyroxine), which is produced by the thyroid gland and has an unfortunate name: thyroxine. One of the reasons for this name is that it looks like the 'active substance' that is present in thyroid hormones. However, the simple fact is that thyroid hormones exist in three separate forms namely human-made, synthesized, and free. Another key factor that is governing the development of the market is the low cost of these tests. In India, thyroid function tests are very inexpensive where the average price of a thyroid test in any NABL-approved lab is around US$ 3.51 to US$ 7. As a result of this, patients are not hesitant and take up the test. Thus, such factors can potentially accelerate growth of the India thyroid function test market. Recently, in January 2020, Horizon Therapeutics Ireland DAC received the U.S. Food and Drug Administration (FDA) approval for Tepezza, the first treatment of thyroid eye disease.
Thyroid function tests are critical in the diagnosis of thyroid disorders. The thyroid disorder is a typical medical condition that keeps the thyroid from making the right amount of hormones. As per the Trends in Thyroid Cancer Incidence in India study, published in May 2018, the incidence rate of thyroid cancer in India in men increased from 0.9 to 1.3 and 2.4 to 3.9 in women during 2004/5 to 2013/14. Such high incidence has increased the demand for adequate testing facilities and tools. Hence, these factors can stimulate growth of the India thyroid test market.
Although there are various factors increasing the adoption of these diagnostics, certain aspects remain prevalent that could potentially hinder the development of the market. For instance, low awareness about thyroid conditions and symptoms is leading to minimal diagnosis. Besides, there is a major concern regarding the use of fraudulent reagents in tests, which can impede growth of the India thyroid function test market.
Hypothyroidism and hyperthyroidism each have different ways of producing their own thyroid hormones. In the case of hypothyroidism, the thyroid gland produces less hormone than it should, while in the case of hyperthyroidism it might produce too much hormone. To diagnose the state of one's thyroid gland one of the most commonly used thyroid hormone blood tests is the thyrotropin tests which are performed with the help of a special kind of probe. Regardless of these limiting factors, continuous investments in R&D activities are likely to provide lucrative growth opportunities for market players in the India thyroid function test market. Besides, research in the field of immunohistochemistry techniques can offer major business opportunities in the near future.

Comments
Post a Comment